Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT)

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10382312" target="_blank" >RIV/00216208:11110/18:10382312 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11150/18:10382312 RIV/00023001:_____/18:00077396

  • Výsledek na webu

    <a href="https://doi.org/10.1016/j.ijcard.2018.06.009" target="_blank" >https://doi.org/10.1016/j.ijcard.2018.06.009</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.ijcard.2018.06.009" target="_blank" >10.1016/j.ijcard.2018.06.009</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT)

  • Popis výsledku v původním jazyce

    Background: Cardiac resynchronization therapy (CRT) improves symptoms of heart failure (HF), morbidity and mortality in selected population. The aim of the study was to investigate the impact of cardiac magnetic resonance (CMR)-guided left ventricular (LV) lead placement on clinical outcomes and LV reverse remodelling in CRT recipients. Methods: Patients with CRT indication were randomized for CMR-guided (CMR group) or electrophysiologically guided (EP group) LV lead placement between 2011 and 2014. The target site in the CMR group was defined as the most delayed, scar-free, in the EP group as the site with the longest interval between the QRS onset and local electrogram. The primary endpoint was a combination of cardiovascular death or HF hospitalization. Secondary endpoints were New York Heart Association (NYHA) Class improvement &gt;= 1, LV endsystolic diameter reduction N10%, B-type natriuretic peptide reduction by &gt;= 30%. Results: A total of 99 patients (47 in the CMR and 52 in the EP group) were enrolled. During amedian follow-up of 47 months, primary composite endpoint occurred in 5 patients in the CMR group and 14 patients in the EP group (HR=0.46; 95% CI: 0.16-1.32). Patients with left bundle branch block and NYHA Class &gt;2 had better clinical outcome in the CMR group (HR=0.09; 95% CI: 0.01-0.75). Conclusions: The use of CMR did not result in significant reduction of combined endpoint of cardiovascular death or HF hospitalization in the total study population. Significant clinical benefit from CMR-guided procedure was observed in a subgroup of optimum CRT candidates with advanced HF. (c) 2018 Elsevier B.V. All rights reserved.

  • Název v anglickém jazyce

    Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT)

  • Popis výsledku anglicky

    Background: Cardiac resynchronization therapy (CRT) improves symptoms of heart failure (HF), morbidity and mortality in selected population. The aim of the study was to investigate the impact of cardiac magnetic resonance (CMR)-guided left ventricular (LV) lead placement on clinical outcomes and LV reverse remodelling in CRT recipients. Methods: Patients with CRT indication were randomized for CMR-guided (CMR group) or electrophysiologically guided (EP group) LV lead placement between 2011 and 2014. The target site in the CMR group was defined as the most delayed, scar-free, in the EP group as the site with the longest interval between the QRS onset and local electrogram. The primary endpoint was a combination of cardiovascular death or HF hospitalization. Secondary endpoints were New York Heart Association (NYHA) Class improvement &gt;= 1, LV endsystolic diameter reduction N10%, B-type natriuretic peptide reduction by &gt;= 30%. Results: A total of 99 patients (47 in the CMR and 52 in the EP group) were enrolled. During amedian follow-up of 47 months, primary composite endpoint occurred in 5 patients in the CMR group and 14 patients in the EP group (HR=0.46; 95% CI: 0.16-1.32). Patients with left bundle branch block and NYHA Class &gt;2 had better clinical outcome in the CMR group (HR=0.09; 95% CI: 0.01-0.75). Conclusions: The use of CMR did not result in significant reduction of combined endpoint of cardiovascular death or HF hospitalization in the total study population. Significant clinical benefit from CMR-guided procedure was observed in a subgroup of optimum CRT candidates with advanced HF. (c) 2018 Elsevier B.V. All rights reserved.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30201 - Cardiac and Cardiovascular systems

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2018

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    International Journal of Cardiology

  • ISSN

    0167-5273

  • e-ISSN

  • Svazek periodika

    270

  • Číslo periodika v rámci svazku

    November

  • Stát vydavatele periodika

    NL - Nizozemsko

  • Počet stran výsledku

    6

  • Strana od-do

    325-330

  • Kód UT WoS článku

    000444609000075

  • EID výsledku v databázi Scopus

    2-s2.0-85048322753